Skip to main content
. 2024 Jun 22;4(3):298–312. doi: 10.1007/s43657-023-00140-y

Fig. 5.

Fig. 5

Schematic and validation of sonodynamic therapy (SDT)-induced pyroptosis. a The design of SDT-pyroptosis nanoparticle; b Validation of morphological changes and effectors of SDT-induced pyroptosis. The sonodynamic nanoparticles were responsive to the low-pH microenvironment of tumors. Chlorin e6 (Ce6) could exert the sonodynamic effect on tumor cells upon irradiation of low-frequency ultrasonic beams by producing cytotoxic reactive oxygen species (ROS). The SDT process consumed oxygen and attenuated hypoxia in cells, enhancing the cell-killing effect of tirapazamine (TPZ). SDT and chemotherapy of TPZ could synergistically trigger pyroptosis of tumor cells. And SDT induced pyroptosis through the caspase-1/GSDMD pathway. The involvement of pyroptosis was verified by detecting cell pyroptotic changes and producing pyroptotic products (Yu et al. 2022). The figure was created with BioRender.com. Printed with permission from Frontiers in Bioengineering and Biotechnology. Copyright 2022, Yu, Cao, Han, Wang, Qiu, Wang, Wei, Wang, Zhang, Liu, Mo and Chen